Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2
Esophagus · 28 authors, 25 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The guidelines address endoscopic surveillance after definitive chemoradiotherapy, noting that intraesophageal recurrence occurs at high incidence even after complete response, necessitating endoscopy at 1 month post-response and every 2–3 months thereafter for 1 year.
Full summary
561 CHARS
The guidelines address endoscopic surveillance after definitive chemoradiotherapy, noting that intraesophageal recurrence occurs at high incidence even after complete response, necessitating endoscopy at 1 month post-response and every 2–3 months thereafter for 1 year. For surgical treatment of cervical esophageal carcinoma, larynx-preserving surgery is discussed, with a caveat that it carries increased risk of aspiration and pneumonia. Late toxicities affect approximately 10% of patients and may be fatal, underscoring the importance of regular follow-up.